{"id":"CHEMBL108","canonicalSmiles":"NC(=O)N1c2ccccc2C=Cc2ccccc21","inchiKey":"FFGPTBGBLSHEPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CARBAMAZEPINE","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arbil mr","Carbagen sr","Carbamazepine","Carbatrol","Carnexiv","Epimaz","Epimaz ret","Epitol","Equetro","Sirtal ret","Tegretol","Tegretol Xr","Tegretol chewtab","Tegretol prolonged release","Tegretol-xr","Teril","Teril ret","Timonil 200 ret","Timonil 400 ret"],"synonyms":["Carbamazepine","G-32883","GEIGY 32883","NSC-169864"],"crossReferences":{"DailyMed":["carbamazepine"],"PubChem":["11110939","11110940","124879629","144203655","144209471","144210515","170464712","17389547","26751576","50104203","56314829","56422193","855967","90341617"],"TG-GATEs":["18"],"Wikipedia":["Carbamazepine"],"drugbank":["DB00564"],"chEBI":["3387"]},"count":13,"approvedIndications":["EFO_0000289","EFO_1001219","EFO_0000474","EFO_0004263","HP_0001250"],"linkedTargets":{"rows":["ENSG00000153253","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0005762","EFO_0002610","EFO_1001219","EFO_0006911","HP_0000726","Orphanet_1956","EFO_0009963","MONDO_0015643","HP_0001250","EFO_0003829","EFO_0000474","EFO_0000289","MONDO_0002050","Orphanet_1945","EFO_0004263","EFO_0000270","EFO_0000764","EFO_0005230","EFO_0000692"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 5 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1081506","canonicalSmiles":"O=C1OC(OC(=O)c2cccnc2Nc2cccc(C(F)(F)F)c2)c2ccccc21","inchiKey":"ANMLJLFWUCQGKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALNIFLUMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Somalgen"],"synonyms":["BA 7602-06","Talniflumate"],"crossReferences":{"PubChem":["144206137","170466420","50112890"],"drugbank":["DB09295"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1083659","canonicalSmiles":"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1","inchiKey":"JYTNQNCOQXFQPK-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUVOREXANT","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Belsomra"],"synonyms":["MK-4305","MK4305","Suvorexant"],"crossReferences":{"DailyMed":["suvorexant"],"drugbank":["DB09034"],"chEBI":["82698"]},"count":8,"approvedIndications":["EFO_0004698"],"linkedTargets":{"rows":["ENSG00000137252","ENSG00000121764"],"count":2},"linkedDiseases":{"rows":["EFO_0004319","EFO_0004262","EFO_0000249","EFO_0003768","EFO_0001358","EFO_0009267","EFO_0005611","EFO_0008568","EFO_0010445","EFO_0004270","EFO_0004698","EFO_0003877","EFO_0003829"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for insomnia and has 7 investigational indications."}
{"id":"CHEMBL1095299","canonicalSmiles":"O=C(O)CCC(=O)OC1N=C(c2ccccc2Cl)c2cc(Br)ccc2NC1=O","inchiKey":"NQTRBZXDWMDXAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14715"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1107","canonicalSmiles":"CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12","inchiKey":"FOHHNHSLJDZUGQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOFANTRINE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Halofantrine"],"crossReferences":{"Wikipedia":["Halofantrine"],"drugbank":["DB01218"]},"childChemblIds":["CHEMBL1966423","CHEMBL1200901"],"count":1,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and is indicated for malaria."}
{"id":"CHEMBL111575","canonicalSmiles":"N=C(N)c1ccc2cc(C(=O)Nc3cccc(OC4CCCC4)c3)ccc2c1","inchiKey":"FWTQOPWAMQXIMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL111575","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07076"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160544","canonicalSmiles":"CC(C)(C)NCC(O)c1cc(O)cc(O)c1.O=S(=O)(O)O","inchiKey":"MUPQZWGSBCWCAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERBUTALINE SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1760","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Brethaire","Brethine","Bricanyl","Terbutaline Sulfate"],"synonyms":["KWD-2019","Terbutaline Sulfate"],"crossReferences":{"PubChem":["26748264","56424025","855787"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1182743","canonicalSmiles":"CCOC(=O)c1c[n+](C)c2n(c1=O)C(C)CCC2","inchiKey":"JOWRFSPJFXLGGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMAZOLIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rimazolium"],"crossReferences":{"drugbank":["DB13289"]},"childChemblIds":["CHEMBL263807"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1200474","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@H](O)[C@H]3C[C@@H]12.Cl","inchiKey":"GVSJQNRGSCOSNJ-KBHRXELFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMECLOCYCLINE HYDROCHLORIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1591","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Declomycin","Demeclocycline hydrochloride","Ledermycin"],"synonyms":["Demeclocycline hydrochloride","Demethylchlortetracycline hydrochloride"],"crossReferences":{"DailyMed":["demeclocycline%20hydrochloride"],"PubChem":["144203905","170465205"],"chEBI":["59725"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960 and has 1 investigational indication."}
{"id":"CHEMBL1200685","canonicalSmiles":"[133Xe]","inchiKey":"FHNFHKCVQCLJFQ-NJFSPNSNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XENON XE 133","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1236802","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xeneisol","Xenon xe 133","Xenon xe 133 gas ampule","Xenon xe 133 gas vials","Xenon xe 133-v.s.s."],"synonyms":["133xe","Xenon (133 xe)","Xenon (133Xe) Gas","Xenon (133xe)","Xenon (133xe) gas","Xenon (133xe) injection","Xenon xe 133","Xenon xe-133"],"crossReferences":{"drugbank":["DB09315"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200847","canonicalSmiles":"N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1.O=S(=O)(O)CCO","inchiKey":"HPLUMRXCPMTSQW-DYVSEJHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYSTILBAMIDINE ISETHIONATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1301","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hydroxystilbamidine Isethionate"],"synonyms":["Hydroxystilbamidine isethionate"],"crossReferences":{"PubChem":["26666922"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200863","canonicalSmiles":"Cl.N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O","inchiKey":"OUUYBRCCFUEMLH-YDALLXLXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MELPHALAN HYDROCHLORIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL852","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alkeran","Evomela","Melphalan hydrochloride"],"synonyms":["CB 3025 HYDROCHLORIDE","CB-3025 HYDROCHLORIDE","Melphalan hydrochloride"],"crossReferences":{"DailyMed":["melphalan%20hydrochloride"],"PubChem":["301128"]},"count":15,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201200","drugType":"Small molecule","blackBoxWarning":false,"name":"GALLIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gallium"],"crossReferences":{"chEBI":["49631"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1201231","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COP(=O)(O)O","inchiKey":"JDOZJEUDSLGTLU-VWUMJDOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNISOLONE PHOSPHORIC ACID","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Prednisolone phosphate","Prednisolone phosphoric acid"],"crossReferences":{"DailyMed":["prednisolone%20sodium%20phosphate"],"drugbank":["DB14631"]},"childChemblIds":["CHEMBL1201014"],"count":1,"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["MP_0001845","EFO_0000270","EFO_0000768","EFO_0007126","EFO_0003929","EFO_0000341","EFO_0007141","EFO_0007308","EFO_0007415"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1973 and has 1 investigational indication."}
{"id":"CHEMBL1201354","canonicalSmiles":"CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1","inchiKey":"NPRHVSBSZMAEIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIDIHEXETHYL","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tridihexethyl"],"crossReferences":{"Wikipedia":["Tridihexethyl"],"drugbank":["DB00505"],"chEBI":["9701"]},"childChemblIds":["CHEMBL2107686","CHEMBL1200771"],"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1201396","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)SCF","inchiKey":"MGNNYOODZCAHBA-GQKYHHCASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUTICASONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluticasone"],"crossReferences":{"Wikipedia":["Fluticasone"],"drugbank":["DB13867"],"chEBI":["5134"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201405","canonicalSmiles":"COc1cc2c(cc1OC)CN(C(=O)[C@H](C)N[C@@H](CCc1ccccc1)C(=O)O)[C@H](C(=O)O)C2","inchiKey":"CMPAGYDKASJORH-YSSFQJQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOEXIPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Moexiprilat"],"crossReferences":{"PubChem":["170466490"],"drugbank":["DB14210"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201431","drugType":"Enzyme","blackBoxWarning":false,"name":"DORNASE ALFA","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pulmozyme"],"synonyms":["Dornase alfa","Dornase alfa (desoxyribonuclease)","Human dnase-1"],"crossReferences":{"DailyMed":["dornase%20alfa"],"DrugCentral":["5135"]},"count":15,"approvedIndications":["Orphanet_586"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for cystic fibrosis and has 14 investigational indications."}
{"id":"CHEMBL1201604","drugType":"Antibody","blackBoxWarning":true,"name":"TOSITUMOMAB","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bexxar"],"synonyms":["Tositumomab"],"crossReferences":{"Wikipedia":["Tositumomab"]},"count":6,"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0000096","EFO_0000095","EFO_0000574","MONDO_0018906","EFO_1001469","EFO_0005952"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201625","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLESTYRAMINE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cholestyramine","Cholestyramine light","Cholybar","Duolite ap143 resin","Locholest","Locholest light","Prevalite","Questran","Questran light"],"synonyms":["Cholestyramine","Cholestyramine resin","Colestyramine"],"crossReferences":{"DailyMed":["cholestyramine"],"DrugCentral":["727"],"Wikipedia":["Cholestyramine"]},"count":8,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 8 investigational indications."}
{"id":"CHEMBL1201736","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1.Cl","inchiKey":"MMRINLZOZVAPDZ-LSGRDSQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1201736","maximumClinicalTrialPhase":0,"parentId":"CHEMBL186","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201747","canonicalSmiles":"CN1CCC(=C2c3ccccc3CCn3c(C=O)cnc32)CC1","inchiKey":"MWTBKTRZPHJQLH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALCAFTADINE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lastacaft"],"synonyms":["Alcaftadine","R 89674","R-89674"],"crossReferences":{"DailyMed":["alcaftadine"],"Wikipedia":["Alcaftadine"],"drugbank":["DB06766"],"chEBI":["71023"]},"count":2,"approvedIndications":["EFO_0007141","EFO_0005751"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0007141","EFO_0005751"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for allergic conjunctivitis and eye allergy."}
{"id":"CHEMBL1201753","canonicalSmiles":"O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1","inchiKey":"VGYFMXBACGZSIL-MCBHFWOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PITAVASTATIN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Itavastatin","Pitavastatin"],"crossReferences":{"DailyMed":["pitavastatin%20calcium","pitavastatin%20magnesium"],"Wikipedia":["Pitavastatin"],"drugbank":["DB08860"],"chEBI":["32020"]},"childChemblIds":["CHEMBL3989923","CHEMBL1237061","CHEMBL3989920"],"count":8,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0002140","HP_0003124","EFO_0001645","EFO_0003774","EFO_0000319","Orphanet_309005","EFO_0000537","EFO_0000195","HP_0000083","EFO_0003144","EFO_0001359","EFO_0003884","Orphanet_79211","HP_0003119","EFO_0007328","EFO_0001360","EFO_0003918"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for cardiovascular disease and has 7 investigational indications."}
{"id":"CHEMBL1213403","canonicalSmiles":"O=C(O)[C@H]1C[C@H]1C(=O)Nc1cc(F)ccc1F","inchiKey":"QTWGHTBKFVANGX-RQJHMYQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213403","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07808"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1218","canonicalSmiles":"CCC(=O)NCC[C@@H]1CCc2ccc3c(c21)CCO3","inchiKey":"YLXDSYKOBKBWJQ-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAMELTEON","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ramelteon","Rozerem"],"synonyms":["Ramelteon","TAK-375","TAK375"],"crossReferences":{"DailyMed":["ramelteon"],"drugbank":["DB00980"]},"count":12,"approvedIndications":["EFO_0004698"],"linkedTargets":{"rows":["ENSG00000168412","ENSG00000134640"],"count":2},"linkedDiseases":{"rows":["EFO_0005296","EFO_0003821","EFO_0002508","EFO_0003768","EFO_0009516","EFO_0009267","EFO_0008568","EFO_0004698","EFO_0007191","EFO_0001422","EFO_0000289","EFO_0003890","MONDO_0002050","EFO_0005295","EFO_0000341","EFO_0003918","EFO_0000692","EFO_0005411","EFO_0007462"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for insomnia and has 11 investigational indications."}
{"id":"CHEMBL1231797","canonicalSmiles":"O=C(Nc1ccc(I)cc1)NC1CCCCC1","inchiKey":"AQTBUVAFYDVTFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231797","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02029"],"chEBI":["41480"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232132","canonicalSmiles":"N[C@@H](Cc1cc(Br)c(O)c(Br)c1)C(=O)O","inchiKey":"COESHZUDRKCEPA-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBROMOTYROSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dibromotyrosine"],"crossReferences":{"PubChem":["4254031","50109387","8139944","99494276"],"drugbank":["DB07637"],"chEBI":["28335"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1233960","canonicalSmiles":"O=C(NCCO)c1ccc(Cl)cc1","inchiKey":"GBARCMIFTACERW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233960","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4252831","91410"],"drugbank":["DB08082"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234282","canonicalSmiles":"CO[C@@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O","inchiKey":"OHWCAVRRXKJCRB-CXNFULCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234282","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03879"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235237","canonicalSmiles":"COc1ccc(-c2nc(-c3cccs3)[nH]c2-c2ccc(OC)cc2)cc1","inchiKey":"XBMULXNXJLWLLD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235237","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08383"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1318341","canonicalSmiles":"Cc1cc2c(cc1S(N)(=O)=O)S(=O)(=O)CCC2","inchiKey":"FNQQBFNIYODEMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METICRANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Meticrane","SD 17102"],"crossReferences":{"PubChem":["11112466","144204046","170465801","56463348"],"drugbank":["DB13284"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL134342","canonicalSmiles":"O=C(O)CCCC[C@@H]1CCSS1","inchiKey":"AGBQKNBQESQNJD-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOCTIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tioctic Acid"],"crossReferences":{"PubChem":["29215172","50107042","90340763"],"Wikipedia":["Lipoic_acid"],"drugbank":["DB00166"],"chEBI":["30314"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1360","canonicalSmiles":"COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC","inchiKey":"YXSLJKQTIDHPOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATRACURIUM","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Atracurium","Tracrium"],"crossReferences":{"DailyMed":["atracurium%20besylate"],"Wikipedia":["Atracurium_besilate"],"chEBI":["2914"]},"childChemblIds":["CHEMBL4584552","CHEMBL1200527"],"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["HP_0001336"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL139393","canonicalSmiles":"O=C(O)C(=O)Nc1sc2c(c1C(=O)O)CCNC2","inchiKey":"ZIBMATWHOAGNTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL139393","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03670"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1452696","canonicalSmiles":"CC(C)=CCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O","inchiKey":"RBBWCVQDXDFISW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEPRAZONE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"," United Kingdom"],"classes":["Dermatological toxicity"],"year":1984},"tradeNames":[],"synonyms":["DA 2370","Feprazone"],"crossReferences":{"PubChem":["144205761","170465969","26758004"],"drugbank":["DB13364"]},"count":3,"approvedIndications":["HP_0002829","HP_0003326","EFO_0005755"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 3 approved indications. It was withdrawn in Germany and  United Kingdom initially in 1984 due to Dermatological toxicity."}
{"id":"CHEMBL1453","canonicalSmiles":"C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O","inchiKey":"XZTUSOXSLKTKJQ-CESUGQOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIGITOXIGENIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Digitoxigenin","Digoxigenin","Uzarigenin"],"crossReferences":{"PubChem":["477480","56463036"],"Wikipedia":["Digitoxigenin"],"drugbank":["DB04177"],"chEBI":["42219"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL15192","canonicalSmiles":"CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O","inchiKey":"QZPQTZZNNJUOLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAPACHONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARQ 501","ARQ-501","Arq 501","Beta-Lapachone","Lapachone","Lapachone, Beta-","MB-12066","NSC-26326","NSC-629749"],"crossReferences":{"PubChem":["11111370","124880531","124880533","124880535","26753601","494711","50106535","50106536","50106537","85231108","90340897"],"drugbank":["DB11948"],"chEBI":["10429"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1551724","canonicalSmiles":"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1N","inchiKey":"RTRQQBHATOEIAF-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACADESINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acadesine","GP-1-110","NSC-105823"],"crossReferences":{"PubChem":["124893186","144205104","170465608","29217492"],"drugbank":["DB04944"],"chEBI":["28498"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL157105","canonicalSmiles":"O=C(O)C1=C(C(=O)Nc2c(F)cc(-c3cccc(OC(F)(F)F)c3)cc2F)CCC1","inchiKey":"VTGXLCZUWFYELR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL157105","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07975"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1614725","canonicalSmiles":"CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21","inchiKey":"ZYQXEVJIFYIBHZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-285","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAK-285","Tak 285","Tak-285"],"count":1,"linkedTargets":{"rows":["ENSG00000146648","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL16476","canonicalSmiles":"CC(C)NCC(O)c1ccc2ccccc2c1","inchiKey":"HRSANNODOVBCST-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRONETALOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Carcinogenicity"],"year":1965},"tradeNames":[],"synonyms":["AY 6204 [AS HYDROCHLORIDE]","GNF-Pf-2670","ICI 38174 [AS HYDROCHLORIDE]","Nethalide","Pronetalol","Pronethalol"],"crossReferences":{"PubChem":["144204478","170466606","26751909"],"chEBI":["8463"]},"childChemblIds":["CHEMBL1876082"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom  in 1965 due to Carcinogenicity."}
{"id":"CHEMBL1651906","canonicalSmiles":"CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"ZSJLQEPLLKMAKR-YDEIVXIUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"STREPTOZOCIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zanosar"],"synonyms":["NSC-37917","NSC-85998","STZ","Streptozocin","Streptozotocin","U-9889"],"crossReferences":{"DailyMed":["streptozocin"]},"count":9,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for neoplasm and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1698011","canonicalSmiles":"CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@]12C","inchiKey":"CMRJPMODSSEAPL-FYQPLNBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRENBOLONE ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Finaplix"],"synonyms":["RU-1697","Trenbolone","Trenbolone acetate"],"crossReferences":{"PubChem":["144205996","50112693"],"drugbank":["DB14660"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743022","drugType":"Antibody","blackBoxWarning":false,"name":"FRESOLIMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fresolimumab","GC-1008","GC1008","GZ-402669","GZ402669"],"count":9,"linkedTargets":{"rows":["ENSG00000105329","ENSG00000119699","ENSG00000092969"],"count":3},"linkedDiseases":{"rows":["EFO_0000404","EFO_0000770","EFO_0000681","EFO_0000768","MONDO_0007254","EFO_0004236","Orphanet_666","EFO_0003833","EFO_0003060"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1754","canonicalSmiles":"CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O","inchiKey":"XFDJYSQDBULQSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXAPRAM","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Doxapram"],"crossReferences":{"DailyMed":["doxapram%20hydrochloride"],"PubChem":["50112713"],"Wikipedia":["Doxapram"],"drugbank":["DB00561"],"chEBI":["681848"]},"childChemblIds":["CHEMBL1200876","CHEMBL3989519"],"count":2,"approvedIndications":["EFO_0000684"],"linkedTargets":{"rows":["ENSG00000169427","ENSG00000171303"],"count":2},"linkedDiseases":{"rows":["EFO_0009444","EFO_0004262","EFO_0000684","EFO_0003917","HP_0002104"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and is indicated for respiratory system disease and has 1 investigational indication."}
{"id":"CHEMBL1765291","canonicalSmiles":"CC(C(=O)O)c1ccc2c(c1)CC(=O)c1ccccc1S2","inchiKey":"MUXFZBHBYYYLTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZALTOPROFEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zaltoprofen"],"crossReferences":{"PubChem":["144207183","170465838"],"drugbank":["DB06737"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL17879","canonicalSmiles":"CCCCC1(CCCC)CS(=O)(=O)c2ccc(N(C)C)cc2[C@@H](c2ccc(OCc3ccc(C[N+]45CCN(CC4)CC5)cc3)cc2)[C@H]1O.[Cl-]","inchiKey":"POMVPJBWDDJCMP-RUKDTIIFSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"MARALIXIBAT CHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL363392","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LUM-001","LUM001","Maralixibat chloride"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1801204","canonicalSmiles":"COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO","inchiKey":"KVLFRAWTRWDEDF-IRXDYDNUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-8055","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZ-12600000","AZD 8055","AZD-8055","AZD8055","Azd-8055"],"crossReferences":{"drugbank":["DB12774"]},"count":7,"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000182","EFO_0000574","EFO_0002499","EFO_0002501","EFO_0000519","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL180570","canonicalSmiles":"O=P(O)(O)CP(=O)(O)O","inchiKey":"MBKDYNNUVRNNRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEDRONIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Medronic acid"],"crossReferences":{"PubChem":["144204525","3714055"],"Wikipedia":["Medronic_acid"],"drugbank":["DB14078"],"chEBI":["43945"]},"childChemblIds":["CHEMBL2105165"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1938870","canonicalSmiles":"O=C(O)Cn1nnc(-c2cc(N3CCC(Oc4cc(F)ccc4Br)CC3)no2)n1","inchiKey":"UJEAABFSXKCSGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-8245","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-8245","Mk-8245"],"crossReferences":{"PubChem":["174006769"],"drugbank":["DB13024"]},"childChemblIds":["CHEMBL2153602"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2001019","canonicalSmiles":"OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1","inchiKey":"PDMUGYOXRHVNMO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04217903","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MET TYROSINE KINASE INHIBITOR PF-04217903","PF-04217903","PF-4217903","Pf-04217903"],"crossReferences":{"PubChem":["103905666","137276005"],"drugbank":["DB12848"]},"childChemblIds":["CHEMBL2170804"],"count":1,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2012521","canonicalSmiles":"CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12.Cl","inchiKey":"WXJMSVGWWYAGRR-FTBISJDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-377604","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2012520","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-377604"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2021423","canonicalSmiles":"O=S(=O)([O-])[O-].[Mg+2]","inchiKey":"CSNNHWWHGAXBCP-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM SULFATE ANHYDROUS","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Magnesium Sulfate Anhydrous"],"synonyms":["Magnesium sulfate","Magnesium sulfate anhydrous"],"crossReferences":{"DailyMed":["magnesium%20sulfate"],"drugbank":["DB00653"],"chEBI":["32599"]},"childChemblIds":["CHEMBL3989857"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 3 investigational indications."}
{"id":"CHEMBL203631","canonicalSmiles":"CO[C@H]1CC[C@H](C(=O)Nc2cc(-c3ccnc(Nc4ccc(F)cc4)c3)ccn2)CC1","inchiKey":"ACGBFWCBVIXTPZ-OQIWPSSASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL203631","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08025"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2067986","canonicalSmiles":"[3H]/C(=N\\N1CC(=O)[N-]C1=O)c1ccc(-c2ccc([N+](=O)[O-])cc2)o1.[Na+]","inchiKey":"KSRLIXGNPXAZHD-SMYAJFCJSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2067986","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201288","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL20852","canonicalSmiles":"Nc1cccc(B(O)O)c1","inchiKey":"JMZFEHDNIAQMNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Aminophenyl Boronic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Aminophenyl Boronic Acid","3-Aminophenylboronic Acid","M-Aminophenylboronic Acid"],"crossReferences":{"PubChem":["26753148"],"drugbank":["DB01896"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103742","drugType":"Small molecule","blackBoxWarning":false,"name":"MANGANESE SULFATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200557","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Manganese sulfate"],"synonyms":["Manganese sulfate"],"crossReferences":{"DrugCentral":["4461"],"chEBI":["86364"]},"count":3,"approvedIndications":["EFO_0004272","EFO_0001070","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 3 approved indications."}
{"id":"CHEMBL2103779","canonicalSmiles":"CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1.O","inchiKey":"UNFQKKSADLVQJE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOBAM","maximumClinicalTrialPhase":1,"parentId":"CHEMBL239800","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenobam","MCN-3377-98"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2103798","canonicalSmiles":"COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1.O=C(O)/C=C\\C(=O)O","inchiKey":"JRMGHBVACUJCRP-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEDIRANIB MALEATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL491473","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Recentin"],"synonyms":["AZD-2171 MALEATE","AZD2171 MALEATE","Cediranib maleat","Cediranib maleate"],"count":19,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 19 investigational indications."}
{"id":"CHEMBL2103929","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(=O)NCNCCCC[C@H](N)C(=O)O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12","inchiKey":"AHEVKYYGXVEWNO-UEPZRUIBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LYMECYCLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tetralysal 150","Tetralysal 300"],"synonyms":["Lymecycline"],"crossReferences":{"drugbank":["DB00256"],"chEBI":["59040"]},"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL2104200","canonicalSmiles":"CCCCN(CCN(CC)CC)C(=O)c1cccc2ccccc12","inchiKey":"WWGZXRYELYWJBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUNAFTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bunaftine"],"crossReferences":{"drugbank":["DB13652"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104208","canonicalSmiles":"CCC(C)(CC)OC(N)=O","inchiKey":"SLWGJZPKHAXZQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMYLCAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emylcamate","KABI 925","MK-250"],"crossReferences":{"drugbank":["DB13572"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104309","canonicalSmiles":"CCOC(C(=O)OCCN(C)C)(c1ccccc1)c1ccccc1","inchiKey":"RHUWRJWFHUKVED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMENOXADOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimenoxadol"],"crossReferences":{"PubChem":["170466465"],"drugbank":["DB01461"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104906","canonicalSmiles":"CC12C=CC(C(=O)O[C@H]3CC[C@H]4[C@@H]5CCC6=CC(=O)CC[C@@H]6[C@H]5CC[C@]34C)(CC1)CC2","inchiKey":"REACBNMPQDINOF-YBBIQVIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NANDROLONE CYCLOTATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nandrolone","Nandrolone cyclohexylpropionate","Nandrolone cyclotate","RS-3268R"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105424","canonicalSmiles":"Fc1cccc(Br)c1NC1=NCCN1","inchiKey":"KDPNLRQZHDJRFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROMIFIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Romifidine"],"crossReferences":{"drugbank":["DB11543"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105660","canonicalSmiles":"CC(C)n1c(=O)c(C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C[C@@H](O)CN(C)S(C)(=O)=O)cc2ccccc21.Cl","inchiKey":"BLIKSWRONBYRDD-ULYYJTHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VELUSETRAG HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2087337","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Velusetrag hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105750","canonicalSmiles":"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3ccccc3)nc3cc(OC)ccc23)CN1C(=O)[C@@H](CC(=O)N1CCCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1","inchiKey":"MHFMTUBUVQZIRE-WINRQGAFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOVAPREVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACH-0141625","Sovaprevir"],"crossReferences":{"drugbank":["DB12069"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106827","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21.CS(=O)(=O)O","inchiKey":"QHLKJRAHRXUJLD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOMEFLOXACIN MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL561","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lomefloxacin mesylate","SC-47111B"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106885","canonicalSmiles":"CC(=O)OC(C)C[N+](C)(C)C.[Br-]","inchiKey":"MMVPLEUBMWUYIB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"METHACHOLINE BROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL978","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methacholine bromide"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107374","canonicalSmiles":"O=C([O-])CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]4[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]5[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]6[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]7[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]8[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]9[C@@H](CSCCC(=O)[O-])O[C@H](O[C@H]1[C@H](O)C2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]","inchiKey":"KMGKABOMYQLLDJ-WXBCEIQXSA-F","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"SUGAMMADEX SODIUM","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2111107","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bridion"],"synonyms":["ORG 25969","ORG-25969","Sugammadex octasodium salt","Sugammadex sodium"],"crossReferences":{"DailyMed":["sugammadex%20sodium"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV that was first approved in 2015."}
{"id":"CHEMBL2107455","canonicalSmiles":"CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1","inchiKey":"ANMATWQYLIFGOK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IGURATIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iguratimod"],"crossReferences":{"PubChem":["144206972"],"drugbank":["DB12233"]},"count":3,"linkedTargets":{"rows":["ENSG00000056972","ENSG00000240972","ENSG00000073756"],"count":3},"linkedDiseases":{"rows":["EFO_0000685","EFO_0005761","EFO_0000699"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108236","drugType":"Unknown","blackBoxWarning":false,"name":"CAPSICUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fiery jack"],"synonyms":["B1353","B1666","B2636","Capsicum","Capsicum annuum","Capsicum annuum fruit","Capsicum annuum fruit extract","Capsicum annuum fruit liquid extract","Capsicum annuum fruit powder","Capsicum annuum tincture","FEMA NO. 2266","FEMA NO. 2833","NDI 448"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2108563","drugType":"Unknown","blackBoxWarning":false,"name":"SILICON DIOXIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Silica gel","Silicon dioxide"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108701","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"HYDROXYETHYL STARCH 130/0.4","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Voluven"],"synonyms":["HES 130/0.4","Hydroxyethyl starch 130/0.4","Volulyte"],"count":6,"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2108733","drugType":"Cell","blackBoxWarning":false,"name":"IXMYELOCEL-T","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ixmyelocel-t"],"count":4,"description":"Cell drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108869","drugType":"Protein","blackBoxWarning":false,"name":"TIPLIMOTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nbi-5788","Tiplimotide"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108882","drugType":"Antibody","blackBoxWarning":false,"name":"SIBROTUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sibrotuzumab"],"count":1,"linkedTargets":{"rows":["ENSG00000078098"],"count":1},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109085","drugType":"Antibody","blackBoxWarning":false,"name":"DETUMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Detumomab","FAVID","SPECIFID"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109323","drugType":"Antibody","blackBoxWarning":false,"name":"IMC-CS4","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMC-CS4","Imc-cs4"],"count":2,"linkedTargets":{"rows":["ENSG00000182578"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109387","drugType":"Antibody","blackBoxWarning":false,"name":"PARSATUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEGF-0444A","MEGF0444A","Parsatuzumab","RG-741","RG-7414","RG7414","anti-EGFL7 monoclonal antibody"],"count":2,"linkedTargets":{"rows":["ENSG00000172889"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","EFO_0003060","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109548","drugType":"Antibody","blackBoxWarning":false,"name":"MK-4721","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGS-1C4D4","AGS-PSCA","MK-4721","Mk-4721"],"count":3,"linkedTargets":{"rows":["ENSG00000167653"],"count":1},"linkedDiseases":{"rows":["EFO_0010282","EFO_0002517","MONDO_0008315"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2135460","canonicalSmiles":"NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O","inchiKey":"BENFXAYNYRLAIU-QSVFAHTRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TERLIPRESSIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Variquel"],"synonyms":["Terlipressin","Terlipressin acetate"],"crossReferences":{"PubChem":["124896640","144206925"],"drugbank":["DB02638"]},"childChemblIds":["CHEMBL4088899"],"count":6,"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2146087","canonicalSmiles":"CCOc1ccccc1OC(c1ccccc1)C1CNCCO1.CS(=O)(=O)O","inchiKey":"CGTZMJIMMUNLQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REBOXETINE MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL14370","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Edronax"],"synonyms":["FCE 20124","PNU-155950E","Reboxetine mesylate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL218415","canonicalSmiles":"CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)[O-])CC3.[Na+]","inchiKey":"DWCYUNBVZHNVET-BTQNPOSSSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL218415","maximumClinicalTrialPhase":0,"parentId":"CHEMBL426559","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2219421","canonicalSmiles":"O=C(O)c1ccc(/C=C/S(=O)(=O)Cc2ccc(Cl)cc2)cc1","inchiKey":"KBEKQQJUNVQLDZ-MDZDMXLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RECILISIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ex-rad"],"synonyms":["ON 01210","ON 01210.Na","On-01210","Recilisib"],"childChemblIds":["CHEMBL2219410"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL225411","canonicalSmiles":"O=C(NCC1CCOCC1)c1cnc(Nc2ccc(Cl)cc2Cl)nc1C(F)(F)F","inchiKey":"TWQYWUXBZHPIIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW842166X","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW 842166","GW 842166X","GW-842166","GW842166","GW842166X","Gw842166x"],"crossReferences":{"PubChem":["174007169"],"Wikipedia":["GW-842,166X"],"drugbank":["DB11903"]},"count":3,"linkedTargets":{"rows":["ENSG00000188822"],"count":1},"linkedDiseases":{"rows":["EFO_0002506","EFO_0004616","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL227954","canonicalSmiles":"N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2ccccc2c1=O","inchiKey":"OYNURZXTLNNKAP-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227954","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08588"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2308782","canonicalSmiles":"C[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](CC(C#N)(c1ccccc1)c1ccccc1)C2.[Br-]","inchiKey":"CWRNUVNMUYSOFQ-ABHLOGGPSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DAROTROPIUM BROMIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2365940","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Darotropium bromide","GSK-233705","GSK-233705B","GSK233705","GSK233705B"],"count":1,"linkedTargets":{"rows":["ENSG00000180720","ENSG00000184984","ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":5},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2347655","canonicalSmiles":"CON(C)C(=O)N1N=C(c2cc(F)ccc2F)S[C@@]1(CCCN)c1ccccc1","inchiKey":"LLXISKGBWFTGEI-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FILANESIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARRY-520","Filanesib"],"crossReferences":{"drugbank":["DB06040"]},"childChemblIds":["CHEMBL3544920"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL234838","canonicalSmiles":"N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2","inchiKey":"YVYPYORTKAIUGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW572738X","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW572738X"],"crossReferences":{"PubChem":["124349907"],"drugbank":["DB07217"],"chEBI":["40300"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2368925","canonicalSmiles":"O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12","inchiKey":"UKTAZPQNNNJVKR-KJGYPYNMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOLASETRON","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dolasetron"],"crossReferences":{"DailyMed":["dolasetron%20mesylate"],"drugbank":["DB00757"]},"childChemblIds":["CHEMBL2373322","CHEMBL2368924"],"count":3,"approvedIndications":["EFO_0006911","HP_0002018"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["EFO_0005687","EFO_0006911","HP_0002017","EFO_0004888","HP_0002018"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for chemotherapy-induced nausea and vomiting and nausea and has 1 investigational indication."}
{"id":"CHEMBL2387144","canonicalSmiles":"COc1cccc(/C=N/N(C(=O)C(F)(F)F)c2ccc(C)cc2C)c1","inchiKey":"HYMZAYGFKNNHDN-SSDVNMTOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"J147","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J-147","J147"],"crossReferences":{"drugbank":["DB13957"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL251935","canonicalSmiles":"Cc1c(CCO)c(=O)oc2cc(O)ccc12","inchiKey":"VCGFYFKJZGIZMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCIMARIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ocimarin"],"crossReferences":{"drugbank":["DB07908"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL254832","canonicalSmiles":"CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1","inchiKey":"NMKSAYKQLCHXDK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENDILINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fendiline"],"crossReferences":{"PubChem":["174006638"],"drugbank":["DB08980"]},"childChemblIds":["CHEMBL1405922"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL259833","canonicalSmiles":"Clc1c[nH]c2ncnc(N3CCc4[nH]cnc4C3)c12","inchiKey":"YFFJXGRXFASBDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL259833","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07585"],"chEBI":["90625"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL26828","canonicalSmiles":"Ic1ccc2c(c1)CNCC2","inchiKey":"FFCFXJXBXUOFIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL26828","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03824"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL272621","canonicalSmiles":"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"DGABKXLVXPYZII-SIBKNCMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYODEOXYCHOLIC_ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AHRO-001","HDCA","Hyodeoxycholic_acid"],"crossReferences":{"Wikipedia":["Hyodeoxycholic_acid"],"drugbank":["DB11789"],"chEBI":["52023"]},"count":1,"linkedTargets":{"rows":["ENSG00000131408","ENSG00000025434"],"count":2},"linkedDiseases":{"rows":["HP_0003124"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL27784","canonicalSmiles":"CC[C@@H](CO)NC(=O)Cc1c(C)n(C(=O)c2ccc(Cl)cc2)c2ccc(OC)cc12","inchiKey":"GKJWXEORYGBJFS-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL27784","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07984"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL281872","canonicalSmiles":"COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1","inchiKey":"YBTGTVGEKMZEQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZD-4190","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ZD-4190"],"childChemblIds":["CHEMBL3544937"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL284671","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.O=S(=O)(O)O","inchiKey":"REJWPZYIFAQSIK-FFHNEAJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CODEINE SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL485","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Codeine Sulfate"],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL28636","canonicalSmiles":"COc1ccc(-c2cc(C(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1F","inchiKey":"WAZQAZKAZLXFMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DERACOXIB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deracoxib","SC-59046"],"crossReferences":{"PubChem":["144205056","170465679","26749318"],"Wikipedia":["Deracoxib"],"drugbank":["DB11395"],"chEBI":["73032"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3125458","canonicalSmiles":"[2H]C([2H])(c1ccc(OC([2H])([2H])C([2H])([2H])[2H])cc1)c1cc([C@]2([2H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)ccc1Cl","inchiKey":"JVHXJTBJCFBINQ-XDNFCDRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3125458","maximumClinicalTrialPhase":0,"parentId":"CHEMBL429910","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL31962","canonicalSmiles":"CCCCB(O)O","inchiKey":"QPKFVRWIISEVCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYL BORONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butyl Boronic Acid","Butylboronic Acid"],"crossReferences":{"drugbank":["DB02664"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL323202","canonicalSmiles":"N=C(NO)Nc1ccc(Cl)cc1","inchiKey":"JYBXKTLYOMPMQY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL323202","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04559"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3338866","canonicalSmiles":"COc1ccc(CNC(=O)c2cc(-c3cncc(Cl)c3)cnc2-c2ccccn2)nc1OC","inchiKey":"CKTWQGHVNRYNCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-1064","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK 1064","Mk-1064"],"crossReferences":{"drugbank":["DB15028"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL343480","canonicalSmiles":"CC(C)=CCOP(=O)(O)OP(=O)(O)O","inchiKey":"CBIDRCWHNCKSTO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLALLYL DIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimethylallyl Pyrophosphate"],"crossReferences":{"drugbank":["DB01785"],"chEBI":["16057"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544973","canonicalSmiles":"CC(=O)O.CCO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1.O","inchiKey":"KRWPPVCZNGQQHZ-IINIBMQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTAROLINE FOSAMIL ACETATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL501122","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Teflaro"],"synonyms":["Ceftaroline fosamil","Ceftaroline fosamil acetate"],"crossReferences":{"chEBI":["70714"]},"count":1,"approvedIndications":["EFO_1001272"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2010 and is indicated for bacterial pneumonia."}
{"id":"CHEMBL3545021","drugType":"Small molecule","blackBoxWarning":false,"name":"ANLOTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL 3818","AL-3818","AL3818","Al-3818","Anlotinib","Catequentinib"],"count":35,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000037280","ENSG00000113721","ENSG00000157404"],"count":4},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003869","EFO_0003820","EFO_1001972","MONDO_0021117","EFO_0000681","EFO_1000657","MONDO_0007254","EFO_0004252","EFO_1001951","MONDO_0001056","EFO_1001480","EFO_0000564","MONDO_0008903","EFO_0000182","MONDO_0015277","EFO_0000616","MONDO_0013730","EFO_0006859","EFO_0005922","MONDO_0002108","MONDO_0024503","MONDO_0008170","Orphanet_44890","EFO_1001968","EFO_0003060","EFO_0005221","EFO_0000311","MONDO_0002912","EFO_0007143","MONDO_0015917","EFO_0008549","EFO_0000174","MONDO_0011962","EFO_0000702","EFO_0000574","MONDO_0002367","EFO_0000691","EFO_0000519","EFO_0001376"],"count":40},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 35 investigational indications."}
{"id":"CHEMBL3545134","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2780301","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ly-2780301"],"count":2,"linkedTargets":{"rows":["ENSG00000175634","ENSG00000105221","ENSG00000117020","ENSG00000108443","ENSG00000142208"],"count":5},"linkedDiseases":{"rows":["EFO_0000574","EFO_0009708"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545269","drugType":"Small molecule","blackBoxWarning":false,"name":"SAR425899","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sar425899"],"count":1,"linkedTargets":{"rows":["ENSG00000215644"],"count":1},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545289","canonicalSmiles":"C[C@@H](NC(=O)Cc1c(Cl)ccc(NCC(F)(F)c2cccc[n+]2O)[n+]1O)c1cccc(Cl)c1","inchiKey":"GNYWBETUYIZBHL-CQSZACIVSA-P","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD2207","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd2207"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545313","canonicalSmiles":"CC(C)(CCCCCC(O)CCCCCC(C)(C)C(=O)O)C(=O)O","inchiKey":"HYHMLYSLQUKXKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEMPEDOIC ACID","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nexletol"],"synonyms":["Bempedoic acid","ESP-55016","ETC-1002","ETC1002"],"crossReferences":{"DailyMed":["bempedoic%20acid"],"drugbank":["DB11936"]},"count":6,"approvedIndications":["EFO_0000319","EFO_0004911"],"linkedTargets":{"rows":["ENSG00000131473"],"count":1},"linkedDiseases":{"rows":["HP_0003124","EFO_0001645","EFO_0003774","EFO_0000319","EFO_0001360","EFO_0004911","Orphanet_309005"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for familial hypercholesterolemia and cardiovascular disease and has 4 investigational indications."}
{"id":"CHEMBL3545399","drugType":"Small molecule","blackBoxWarning":false,"name":"R-112","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-112"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545406","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2940094","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ly2940094"],"count":3,"linkedTargets":{"rows":["ENSG00000125510"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009","EFO_0003829"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3647420","canonicalSmiles":"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C","inchiKey":"SADXACCFNXBCFY-IYNHSRRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3647420","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14993"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3681419","canonicalSmiles":"Cc1onc(-c2ccc(F)cc2)c1COc1ccc(C(=O)N2CCS(=O)(=O)CC2)cn1","inchiKey":"VCGRFBXVSFAGGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BASMISANIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Basmisanil","RG-1662","RG1662","RO-5186582","RO5186582","Rg1662"],"crossReferences":{"drugbank":["DB11877"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707363","canonicalSmiles":"CC(CC(c1ccccc1)c1ccccc1)N(C)C","inchiKey":"NSHMKXVHJBBKTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHYLDIPHENYLPROPYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trimethyldiphenylpropylamine"],"crossReferences":{"drugbank":["DB13361"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL370805","canonicalSmiles":"COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C","inchiKey":"ZPUCINDJVBIVPJ-LJISPDSOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"COCAINE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cocaine","IDS-NC-004","RX-0041","RX0041"],"crossReferences":{"DailyMed":["cocaine%20hydrochloride"],"drugbank":["DB00907"],"chEBI":["27958"]},"childChemblIds":["CHEMBL529437"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL374975","canonicalSmiles":"CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\\CCC=C(C)C)C(=O)O","inchiKey":"IECPWNUMDGFDKC-MZJAQBGESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FUSIDIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fucidin caviject","Fucithalmic"],"synonyms":["CEM-102","Fusidic acid","NSC-56192","SQ 16,603","SQ-16603"],"crossReferences":{"Wikipedia":["Fusidic_acid"],"drugbank":["DB02703"],"chEBI":["29013"]},"childChemblIds":["CHEMBL1256987"],"count":6,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for eye infection and bacterial disease and has 4 investigational indications."}
{"id":"CHEMBL376185","canonicalSmiles":"CCC[C@@H]1C[C@@H](C(=O)NC(C(C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1","inchiKey":"KDLRVYVGXIQJDK-NOWPCOIGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL376185","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01190"],"chEBI":["3745"]},"childChemblIds":["CHEMBL1490142"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833330","drugType":"Antibody","blackBoxWarning":false,"name":"CINPANEMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-054","BIIB054","Biib054","Cinpanemab"],"count":1,"linkedTargets":{"rows":["ENSG00000145335"],"count":1},"linkedDiseases":{"rows":["EFO_0002508"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL383570","canonicalSmiles":"O=C(O)C(=O)Nc1cc2ccccc2cc1C(=O)O","inchiKey":"DQBLKSRRWDWNKQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL383570","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01734"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL384759","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"QGWNDRXFNXRZMB-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL384759","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756683"],"Wikipedia":["Guanosine_diphosphate"],"drugbank":["DB04315"],"chEBI":["17552"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL386049","canonicalSmiles":"NS(=O)(=O)c1ccc(NC(=O)c2ccccc2S)cc1","inchiKey":"MRLVIVXGUGNENL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-(2-Mercaptophenylcarboxamido)Benzenesulfonamide","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-(2-Mercaptophenylcarboxamido)Benzenesulfonamide"],"crossReferences":{"drugbank":["DB07476"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989820","canonicalSmiles":"Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1.Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"VXRDAMSNTXUHFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ZOLPIDEM TARTRATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL911","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ambien","Ambien cr","Edluar","Intermezzo","Stilnoct","Tovalt odt","Zolpidem tartrate","Zolpimist"],"synonyms":["SL 80.0750-23N","SL-80.0750","SL-80.0750-23N","Zolpidem tartrate","Zolpidem tartrate civ"],"crossReferences":{"DailyMed":["zolpidem%20tartrate"]},"count":2,"approvedIndications":["EFO_0004698"],"linkedTargets":{"rows":["ENSG00000113327","ENSG00000163288"],"count":2},"linkedDiseases":{"rows":["EFO_0001073","EFO_0004698"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for insomnia and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989871","canonicalSmiles":"Cc1ccc(NC(=O)[C@H]2CCCN(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC3CCCC3)cc2)cc1C(F)(F)F","inchiKey":"PUKBOVABABRILL-YZNIXAGQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVACOPAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avacopan","CCX-168","CCX168","Ccx168"],"crossReferences":{"drugbank":["DB15011"]},"count":5,"linkedTargets":{"rows":["ENSG00000197405"],"count":1},"linkedDiseases":{"rows":["EFO_0006803","Orphanet_2134","EFO_1000710","EFO_0004826","EFO_0004194","Orphanet_329918"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL404422","canonicalSmiles":"CCCCC1(CC)C(=O)NC(=O)NC1=O","inchiKey":"STDBAQMTJLUMFW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTETHAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neonal","Soneryl"],"synonyms":["Butethal","Butobarbital","Butobarbitone"],"crossReferences":{"Wikipedia":["Butobarbital"],"drugbank":["DB01353"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL405346","canonicalSmiles":"CSC[C@H]1CN(Cc2c[nH]c3c(N)ncnc23)C[C@@H]1O","inchiKey":"NTHMDFGHOCNNOE-ZJUUUORDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL405346","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08606"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4068311","canonicalSmiles":"CC(=O)O.N=C(N)NCCCC[C@@H]1NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O","inchiKey":"KWKBRYJYRIUYEI-QMYFOHRPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4068311","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1174","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL41172","canonicalSmiles":"Oc1cccc(Cl)c1","inchiKey":"HORNXRXVQWOLPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Chloro-Phenol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Chloro-Phenol","3-Chlorophenol"],"crossReferences":{"PubChem":["144208031","17388933"],"drugbank":["DB01957"],"chEBI":["38855"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL412531","canonicalSmiles":"CC[C@H](C)[C@@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CS)C(C)C)C(C)C)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(=O)O)C(=O)O)C(C)C)C(C)C)C(C)C)[C@H](C)O","inchiKey":"LCJVIYPJPCBWKS-NXPQJCNCSA-N","drugType":"Protein","blackBoxWarning":false,"name":"THYMOSIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thymosin"],"count":5,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL422704","canonicalSmiles":"CCCCCc1cc(O)c2c(c1)OC(C)(CCC=C(C)C)C=C2","inchiKey":"UVOLYTDXHDXWJU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANNABICHROMENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cannabichromene"],"crossReferences":{"Wikipedia":["Cannabichromene"],"drugbank":["DB14735"],"chEBI":["3357"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297215","canonicalSmiles":"O=C1c2c(O)c(=O)ccn2N([C@@H]2c3ccccc3SCc3c2ccc(F)c3F)[C@@H]2COCCN12","inchiKey":"FIDLLEYNNRGVFR-CTNGQTDRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALOXAVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Baloxavir","S-033447"],"crossReferences":{"drugbank":["DB15675"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297539","canonicalSmiles":"CC(=O)N[C@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"MBLBDJOUHNCFQT-WCTZXXKLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-ACETYLMANNOSAMINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mannac","N-acetylmannosamine"],"crossReferences":{"drugbank":["DB12536"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297570","drugType":"Unknown","blackBoxWarning":false,"name":"AMP-224","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amp-224","GSK-2661380"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297626","canonicalSmiles":"Cn1nc(C(=O)N(Cc2ccccc2)Cc2ccc(C(=O)O)cc2)c2c1-c1cc(Cl)ccc1OC2","inchiKey":"JYTIXGYXBIBOMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIDUFEXOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LMB763","Lmb763","Nidufexor"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297668","canonicalSmiles":"CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2.O=C(O)/C=C\\C(=O)O","inchiKey":"DGVCEXQFNYYRQI-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILCICLIB MALEATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL564829","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Milciclib maleate","PHA-848125AC","Pha-848125ac"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297817","drugType":"Unknown","blackBoxWarning":false,"name":"QS-21","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["QS21","Qs-21","SAPONIN QA-21V1"],"count":13,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL4297868","drugType":"Enzyme","blackBoxWarning":false,"name":"RECOMBINANT HUMAN LECITHIN:CHOLESTEROL ACYLTRANSFERASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACP-501","Acp-501","MEDI-6012","MEDI6012","Medi 6012","Medi6012","Recombinant human lecithin:cholesterol acyltransferase"],"count":3,"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297988","drugType":"Enzyme","blackBoxWarning":false,"name":"IDURSULFASE BETA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hunterase","Idursulfase beta"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298020","drugType":"Antibody","blackBoxWarning":false,"name":"LODAPOLIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3300054","LY3300054","Lodapolimab","Ly 3300054","Ly-3300054","Ly3300054"],"count":5,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4298045","drugType":"Antibody","blackBoxWarning":false,"name":"INDUSATUMAB VEDOTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indusatumab vedotin","MLN-0264","MLN0264","Mln0264","TAK-264"],"count":2,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000070019","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_1000044","EFO_0000503","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298083","drugType":"Protein","blackBoxWarning":false,"name":"BALORAMOTIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Baloramotide","Recombinant ny-eso-1 protein"],"count":2,"description":"Protein drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298151","canonicalSmiles":"CS(=O)(=O)O.CS(=O)(=O)O.Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1","inchiKey":"LNSQWHNDOWEZII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRANSERTIB MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL4297188","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARQ 092 mesylate","Miransertib mesylate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL436559","canonicalSmiles":"CC(C)c1ccc(C(=O)N=C(N)N)cc1S(C)(=O)=O","inchiKey":"IWXNYAIICFKCTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARIPORIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cariporide","HOE-642"],"crossReferences":{"Wikipedia":["Cariporide"],"drugbank":["DB06468"]},"childChemblIds":["CHEMBL462831"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL437","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2nccs2)cc1","inchiKey":"JNMRHUJNCSQMMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFATHIAZOLE","yearOfFirstApproval":1945,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Thiazamide"],"synonyms":["Sulfathiazole","Sulfathiazole (triple sulfa)","Sulphathiazole"],"crossReferences":{"PubChem":["11112198","144203914","144209441","144213555","170465454","17388718","26747309","56463345","90559"],"Wikipedia":["Sulfathiazole"],"drugbank":["DB06147"],"chEBI":["9337"]},"childChemblIds":["CHEMBL3780934","CHEMBL2107243"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1945 and is indicated for bacterial disease. It was withdrawn in United States."}
{"id":"CHEMBL4594382","canonicalSmiles":"O=P(O)(O)O.[2H]C1([2H])C([C@@H](CC#N)n2cc(-c3ncnc4[nH]ccc34)cn2)C([2H])([2H])C([2H])([2H])C1([2H])[2H]","inchiKey":"JFMWPOCYMYGEDM-NTVOUFPTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEURUXOLITINIB PHOSPHATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1789941","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C-21543 phosphate","CTP-543 phosphate","D8- ruxolitinib phosphate","Deuruxolitinib phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594503","drugType":"Antibody","blackBoxWarning":false,"name":"TALQUETAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-63483043","Talquetamab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL467084","canonicalSmiles":"N[C@@H](Cc1ccccn1)c1ccccc1","inchiKey":"FWUQWDCOOWEXRY-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANICEMINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-R15896AR","AZD-6765","AZD6765","Azd6765","Lanicemine"],"crossReferences":{"drugbank":["DB11889"]},"count":2,"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000161509","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL484785","canonicalSmiles":"N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1","inchiKey":"USZAGAREISWJDP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CRISABOROLE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eucrisa"],"synonyms":["AN-2728","AN2728","Crisaborole"],"crossReferences":{"DailyMed":["crisaborole"],"PubChem":["174007043"],"drugbank":["DB05219"]},"count":6,"approvedIndications":["HP_0000964","EFO_0000274"],"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["EFO_0004192","HP_0000964","EFO_1000764","MONDO_0002406","EFO_0000676","EFO_1001361","EFO_0000274"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for atopic eczema and eczema and has 4 investigational indications."}
{"id":"CHEMBL502835","canonicalSmiles":"COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1","inchiKey":"XZXHXSATPCNXJR-ZIADKAODSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NINTEDANIB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ofev","Vargatef"],"synonyms":["BIBF 1120","BIBF-1120","BIBF1120","Bibf-1120","Intedanib","Nintedanib"],"crossReferences":{"DailyMed":["nintedanib%20esylate"],"drugbank":["DB09079"],"chEBI":["85164"]},"childChemblIds":["CHEMBL3039504"],"count":45,"approvedIndications":["EFO_0000616","EFO_0000768"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000066468","ENSG00000068078","ENSG00000102755","ENSG00000037280","ENSG00000077782","ENSG00000160867","ENSG00000113721"],"count":9},"linkedDiseases":{"rows":["EFO_0007183","EFO_0000571","EFO_0000768","EFO_0000681","EFO_1001465","MONDO_0007254","MONDO_0021117","EFO_0000708","Orphanet_538","MONDO_0002087","MONDO_0044937","EFO_1001951","MONDO_0002158","EFO_0000588","EFO_1001331","MONDO_0008903","EFO_0000182","EFO_0000389","EFO_0000673","EFO_0004244","EFO_0008528","EFO_0000770","MONDO_0015277","EFO_0002499","EFO_0000717","EFO_1001949","EFO_0001416","EFO_0000616","EFO_0002618","EFO_0003893","EFO_0000503","MONDO_0008170","MONDO_0004669","EFO_0000222","EFO_0002501","EFO_0002500","EFO_0004243","EFO_0003060","EFO_0009448","MONDO_0100096","MONDO_0011962","MONDO_0001235","EFO_0004142","EFO_0000702","EFO_0004284","EFO_0001378","EFO_0000691","EFO_0000519"],"count":48},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for idiopathic pulmonary fibrosis and neoplasm and has 43 investigational indications."}
{"id":"CHEMBL512341","canonicalSmiles":"COc1ccccc1-c1cc2c(c3c1C(=O)NC3=O)c1cc(O)ccc1n2CCCO","inchiKey":"AOGOZJCRIFBTTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL512341","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07006"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL539423","canonicalSmiles":"CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)Nc2noc(C)c2C)c(COCC)c1","inchiKey":"WRFHGDPIDHPWIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPARSENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PS-433540","PS433540","RE-021","Sparsentan"],"crossReferences":{"drugbank":["DB12548"]},"count":3,"linkedTargets":{"rows":["ENSG00000151617","ENSG00000144891"],"count":2},"linkedDiseases":{"rows":["EFO_0004236","EFO_0004194","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL540445","canonicalSmiles":"C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21","inchiKey":"KTEXNACQROZXEV-SLXBATTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARTHENOLIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-157035","Parthenolide"],"crossReferences":{"Wikipedia":["Parthenolide"],"drugbank":["DB13063"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL560976","canonicalSmiles":"NC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)O1","inchiKey":"JJCQSGDBDPYCEO-XVZSLQNASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBEKACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dibekacin","Dibekacin sulfate"],"crossReferences":{"PubChem":["144205049"],"Wikipedia":["Dibekacin"],"drugbank":["DB13270"],"chEBI":["37945"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL56900","canonicalSmiles":"c1ccc(Cn2c(N3CCNCC3)nc3ccccc32)cc1","inchiKey":"PWWDCRQZITYKDV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LERISETRON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lerisetron"],"crossReferences":{"Wikipedia":["Lerisetron"],"drugbank":["DB12964"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL572","canonicalSmiles":"O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1","inchiKey":"NXFQHRVNIOXGAQ-YCRREMRBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITROFURANTOIN","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Berkfurin","Ceduran","Dantafur","Furadantin","Furalan","Genfura","Macrobid","Macrodantin","Nitrofurantoin","Nitrofurantoin (monohydrate/macrocrystals)","Nitrofurantoin macrocrystalline"],"synonyms":["Ivadantin","NSC-2107","NSC-44150","Nitrofurantoin","Nitrofurantoin, macrocrystalline"],"crossReferences":{"DailyMed":["nitrofurantoin","nitrofurantoin,%20macrocrystalline"],"PubChem":["17389788","26747377"],"TG-GATEs":["20"],"Wikipedia":["Nitrofurantoin"],"drugbank":["DB00698"],"chEBI":["71415"]},"childChemblIds":["CHEMBL1201000"],"count":5,"approvedIndications":["EFO_0003103","EFO_0000771","EFO_1000025"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL576960","canonicalSmiles":"COc1cc(-c2cc(C)cc(C)c2)cc([C@@H](C)C#Cc2c(C)nc(N)nc2N)c1","inchiKey":"ATFDKOLABYIYCC-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL576960","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07142"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL578780","canonicalSmiles":"[2H]O[C@H]1C[C@H](O[2H])C/C(=C/C=C2\\CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O[2H])C1=C","inchiKey":"GMRQFYUYWCNGIN-GJPRAFLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"14Alpha-H,1Alpha,25-Dihydroxyvitamin D3","maximumClinicalTrialPhase":0,"parentId":"CHEMBL846","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["14Alpha-H,1Alpha,25-Dihydroxyvitamin D3"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL607048","canonicalSmiles":"COCC[C@H]1CC2CN3CCc4c([nH]c5ccccc45)[C@](C(=O)OC)(C2)[C@H]13","inchiKey":"DTJQBBHYRQYDEG-JNBMDGLNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"18-METHOXYCORONARIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["18-methoxycoronaridine"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL609","canonicalSmiles":"NCCNCCNCCN","inchiKey":"VILCJCGEZXAXTO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIENTINE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-443","Syprine","Trientine"],"crossReferences":{"DailyMed":["trientine%20hydrochloride"],"PubChem":["144204713","144208264","170465257","17389525"],"Wikipedia":["Triethylenetetramine"],"drugbank":["DB06824"],"chEBI":["39501"]},"childChemblIds":["CHEMBL1200783","CHEMBL3989777"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 3 investigational indications."}
{"id":"CHEMBL63859","canonicalSmiles":"OCC(CO)(CO)NCCCNC(CO)(CO)CO","inchiKey":"HHKZCCWKTZRCCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL63859","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Bis-tris_propane"],"drugbank":["DB02676"],"chEBI":["40947"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL7002","canonicalSmiles":"CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1","inchiKey":"YZFWTZACSRHJQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIGLITAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADD-3878","Ciglitazone","U-63287"],"crossReferences":{"PubChem":["144205673","170466553","26752160","26752161","26752162","26757865"],"Wikipedia":["Ciglitazone"],"drugbank":["DB09201"],"chEBI":["64227"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL7863","canonicalSmiles":"C=CCC1(C(C)C)C(=O)NC(=O)NC1=O","inchiKey":"UORJNBVJVRLXMQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APROBARBITAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Alurate"],"synonyms":["Allypropymal","Aprobarbital"],"crossReferences":{"Wikipedia":["Aprobarbital"],"drugbank":["DB01352"],"chEBI":["2791"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL79","canonicalSmiles":"CCN(CC)CC(=O)Nc1c(C)cccc1C","inchiKey":"NNJVILVZKWQKPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LIDOCAINE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine"],"crossReferences":{"DailyMed":["lidocaine","lidocaine%20hydrochloride"],"PubChem":["104171182","11111384","11111385","144203734","170464729","26751483","26751484","56422194","855682","90340642"],"Wikipedia":["Lidocaine"],"drugbank":["DB00281"],"chEBI":["6456"]},"childChemblIds":["CHEMBL3278065","CHEMBL541521","CHEMBL1200409"],"count":87,"approvedIndications":["HP_0003326","HP_0000989","EFO_0002506","EFO_0004269","EFO_0005856","EFO_0009846","EFO_0009552","EFO_0003843","EFO_1001434","EFO_1000941"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_1000910","EFO_0001361","EFO_0002610","EFO_0009540","EFO_1001178","EFO_0010822","HP_0030838","EFO_0007486","EFO_0000555","MONDO_0002959","EFO_0005952","EFO_0005773","EFO_1001951","HP_0100543","EFO_0003103","EFO_0003931","MONDO_0016047","EFO_1001366","EFO_0009582","MONDO_0008903","EFO_0004616","EFO_0009620","EFO_0000400","MONDO_0002635","EFO_1001904","EFO_0005762","EFO_0003888","EFO_0002618","EFO_1000864","HP_0012532","HP_0002619","EFO_0001663","EFO_0002496","EFO_0000546","MP_0001914","MONDO_0002691","EFO_0009688","HP_0000951","EFO_0003957","EFO_0000574","HP_0100607","MONDO_0002258","EFO_1001887","EFO_1001434","EFO_0003943","MONDO_0018373","EFO_1001896","EFO_0005687","EFO_0001365","MONDO_0007254","EFO_0000284","EFO_0008568","EFO_0009430","EFO_0003100","EFO_0004143","EFO_0001069","EFO_0000707","EFO_1000249","EFO_1002005","EFO_0004799","EFO_0004210","EFO_0004269","EFO_0001645","EFO_0003898","EFO_0004198","EFO_0000319","HP_0003418","EFO_0001073","EFO_0003843","HP_0002315","EFO_0000537","HP_0000713","EFO_0003885","EFO_1001412","HP_0001082","EFO_0010582","EFO_0000649","EFO_1001087","HP_0000020","EFO_0004273","MONDO_0001572","EFO_0009492","EFO_0003777","EFO_1001139","HP_0000989","HP_0012735","EFO_1001919","MONDO_0004567","EFO_0000565","EFO_1000889","Orphanet_365","EFO_0002506","EFO_0000544","MONDO_0002471","EFO_1001898","EFO_0006510","HP_0003419","EFO_1000789","EFO_0009552","EFO_1001250","HP_0000360","EFO_0005296","EFO_0001074","EFO_0005856","EFO_0003821","HP_0009762","EFO_0000701","EFO_0009516","EFO_0000294","HP_0003326","MP_0001845","EFO_1001240","HP_0030833","EFO_0000731","EFO_0009951","EFO_0003033","EFO_0009676","HP_0030680","EFO_0000668","EFO_0002970","EFO_0001059","EFO_1001998","EFO_1001219","EFO_0006834","EFO_1001435","EFO_0008507","EFO_0009846","EFO_0000305","EFO_0002950","EFO_1000783","HP_0030834","EFO_0000712","EFO_0009619","EFO_1001993","EFO_0003932","EFO_0002460","EFO_0005279","EFO_0003917","EFO_0003030","EFO_0005230","HP_0001822","EFO_0000545","EFO_0000313","EFO_1001054","HP_0003394","EFO_0003894","EFO_1000941","EFO_0007214","EFO_0005754","EFO_0000311","HP_0001907","EFO_1001097","EFO_0003890","EFO_0003901","EFO_0003854","EFO_0004142","EFO_1000781","EFO_0003766","EFO_0005611","EFO_0003833"],"count":160},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and has 10 approved and 77 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL79512","canonicalSmiles":"NCCCCc1ccccc1","inchiKey":"AGNFWIZBEATIAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-PHENYL-BUTYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Phenyl-Butylamine","4-Phenylbutylamine"],"crossReferences":{"drugbank":["DB04311"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL813","canonicalSmiles":"CCCCc1ncc(/C=C(\\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1","inchiKey":"OROAFUQRIXKEMV-LDADJPATSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"EPROSARTAN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Teveten"],"synonyms":["Eprosartan","SK&F 108566","SK&F-108566","SK-108566","Teveten"],"crossReferences":{"DailyMed":["eprosartan%20mesylate"],"Wikipedia":["Eprosartan"],"drugbank":["DB00876"],"chEBI":["4814"]},"childChemblIds":["CHEMBL1200987"],"count":3,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_1002032","EFO_0000319","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for cardiovascular disease and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL837","canonicalSmiles":"CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC","inchiKey":"FJHBVJOVLFPMQE-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"7-ETHYL-10-HYDROXYCAMPTOTHECIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7-Ethyl-10-Hydroxy-Camptothecin","7-ethyl-10-hydroxycamptothecin","IT-141","Irinotecan related compound b","It-141","NK 012","NK-012","NK012","Nk012","SN 38","SN-38"],"crossReferences":{"PubChem":["515301"],"Wikipedia":["SN-38"],"drugbank":["DB05482"],"chEBI":["8988"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL844","canonicalSmiles":"Brc1c(NC2=NCCN2)ccc2nccnc12","inchiKey":"XYLJNLCSTIOKRM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRIMONIDINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AGN-190342 FREE BASE","Brimonidine","UK-14304","UK-1430418 FREE BASE"],"crossReferences":{"DailyMed":["brimonidine%20tartrate"],"PubChem":["104171261","11111939","11113354","144203850","170464941","26751556","50104157","85231282","855898","90340645"],"Wikipedia":["Brimonidine"],"drugbank":["DB00484"],"chEBI":["3175"]},"childChemblIds":["CHEMBL1200389","CHEMBL2062257"],"count":7,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["MONDO_0001330","EFO_0004190","EFO_1001069","HP_0010783","EFO_0001365","EFO_1000879","EFO_1000906","EFO_0003770","MONDO_0008315","HP_0031284","Orphanet_791","EFO_0009606","EFO_0003885","EFO_1000760","EFO_1001022","EFO_0005240","MONDO_0021698","EFO_0007141","EFO_0000516","EFO_1001893","EFO_0003822"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for glaucoma and has 6 investigational indications."}
{"id":"CHEMBL85398","canonicalSmiles":"O=C1CSC(=O)N1","inchiKey":"ZOBPZXTWZATXDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAZOLIDINEDIONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thiazolidine-2,4-Dione","Thiazolidinedione"],"crossReferences":{"drugbank":["DB11898"],"chEBI":["50992"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL865","canonicalSmiles":"Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1","inchiKey":"LNPDTQAFDNKSHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VALDECOXIB","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"," Neurotoxicity"],"year":2004},"tradeNames":["Bextra"],"synonyms":["SC-65872","Valdecoxib"],"crossReferences":{"PubChem":["144204991","170465163","26748964","49665731"],"Wikipedia":["Valdecoxib"],"drugbank":["DB00580"],"chEBI":["63634"]},"count":6,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002506","EFO_0000278","EFO_0004616","HP_0003419","HP_0100607","EFO_1002012","MONDO_0002258","EFO_0003843","EFO_0005755"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for rheumatic disease and has 5 investigational indications. It was withdrawn in United States  in 2004 due to Cardiotoxicity and  Neurotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL904","canonicalSmiles":"COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1.Cl","inchiKey":"JUMYIBMBTDDLNG-OJERSXHUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL827","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dexmethylphenidate hydrochloride","Focalin","Focalin xr"],"synonyms":["Dexmethylphenidate hydrochloride","Methylphenidate d-threo-form hydrochloride"],"crossReferences":{"DailyMed":["dexmethylphenidate%20hydrochloride"]},"count":1,"approvedIndications":["EFO_0003888"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0003888"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2001 and is indicated for attention deficit hyperactivity disorder. This drug has a black box warning from the FDA."}
{"id":"CHEMBL90593","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CCC2=O","inchiKey":"FMGSKLZLMKYGDP-USOAJAOKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRASTERONE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dhea","Enzymatic therapy","Intrarosa","Natrol dhea"],"synonyms":["Dehydroandrosterone","Dehydroepiandrosterone","EM-760","NSC-9896","Prasterone"],"crossReferences":{"DailyMed":["prasterone"],"PubChem":["144204773","144209194","144213078","170465614","26753548","29215152","50106135","50106136","56320669","75250"],"Wikipedia":["Dehydroepiandrosterone"],"drugbank":["DB01708"],"chEBI":["28689"]},"count":29,"approvedIndications":["EFO_0000685","EFO_0002506","HP_0100607","EFO_0003843"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 4 approved and 25 investigational indications."}
{"id":"CHEMBL964","canonicalSmiles":"CCN(CC)C(=S)SSC(=S)N(CC)CC","inchiKey":"AUZONCFQVSMFAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DISULFIRAM","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antabuse","Disulfiram","Esperal"],"synonyms":["Disulfiram","NSC-25953","ORA-102","ORA102"],"crossReferences":{"DailyMed":["disulfiram"],"PubChem":["104171249","11111859","11111860","11533044","123060006","124881563","124881565","124881567","124881570","144203831","144210721","144214033","170464767","26747681","26747682","26753660","26753661","50107088","50107089","56422197","85231246","90340564"],"TG-GATEs":["109"],"Wikipedia":["Disulfiram"],"drugbank":["DB00822"],"chEBI":["4659"]},"count":15,"approvedIndications":["EFO_0001067","EFO_0003829"],"linkedTargets":{"rows":["ENSG00000111275"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","EFO_0000756","MONDO_0007254","EFO_0003060","MONDO_0008315","EFO_0003829","EFO_0000311","EFO_1000044","MONDO_0100096","MONDO_0021698","EFO_0000764","EFO_0001378","EFO_0005611","EFO_0004701","EFO_0001067","EFO_0000514","EFO_0000519","EFO_0002617"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1951 and is indicated for parasitic infection and alcohol dependence and has 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL980","canonicalSmiles":"COc1ccccc1OCC(O)CO","inchiKey":"HSRJKNPTNIJEKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUAIFENESIN","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amonidron","Famel","Franolyn chesty","Gecolate","Glycerol Guaiacolate","Guaifenesin","Guaiphenesin","Liqufruta","Mucinex","Nirolex for chesty cough decongestant","Robitussin","Tixylix chesty cough"],"synonyms":["CVT-2534","Glyceryl guaiacolate","Guaiacol glyceryl ether","Guaifenesin","Guaiphenesin","Humabid","Methphenoxydiol","NSC-62112"],"crossReferences":{"DailyMed":["guaifenesin"],"PubChem":["11532912","144212411","170464855","26748064"],"Wikipedia":["Guaifenesin"],"drugbank":["DB00874"]},"count":4,"approvedIndications":["EFO_0007486"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for sinusitis and has 3 investigational indications."}
